.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, Kings & Queens leaned heavily into Flower at 77.27% share, yet that anchor category posted a -12.95% month-over-month shift even as its year-over-year change printed at 253,420.45%, indicating a base-effect surge that is now cooling. The mix pivoted toward Pre-Roll and Concentrates, with Pre-Roll reaching 9.78% share on 80.62% MoM growth and 2,050.69% YoY, while Concentrates climbed to 9.82% share with 107.40% MoM and 255.97% YoY; Vapor Pens slipped to 3.13% share with -39.11% MoM despite 53.47% YoY. With the average price at $28.48 and a -13.17% YoY price change, the pattern implies volume-led expansion concentrated in lower-priced formats and an ongoing rebalancing away from a single-category dependence as Flower’s outsized YoY dissipates and faster MoM growth concentrates in Pre-Roll and Concentrates.
This mix shift positions Kings & Queens to trade into baskets where trial and repeat can accelerate, as the 80.62% MoM in Pre-Roll and 107.40% MoM in Concentrates redistribute risk from Flower’s -12.95% MoM while maintaining exposure to its 253,420.45% YoY legacy spike. Holding the top-category footprint in Flower while ranking 37th in Flower in New York creates headroom: translating the 9.78% and 9.82% shares in Pre-Roll and Concentrates into sustained double-digit mix would counter the 3.13% share in Vapor Pens and leverage the -13.17% YoY price to support trial, implying a positioning path that favors breadth across inhalables and mitigates volatility tied to Flower rank at 37.
Competitive Landscape
Kings & Queens is currently ranked #37 in NY Flower in May 2026, a 4-position improvement from #41 three months prior, while still trailing its peak of #32 reached in April 2026; meanwhile, Leal moved to #1 with a 10-position year-over-year climb from #11, and Dank. By Definition sits at #2 despite a 38.1% year-over-year sales decline, indicating that Kings & Queens’ incremental rank gains are occurring in a tier where top spots are being reshuffled by sharper upward and downward movements. This combination of a 5-rank gap to April 2026’s peak and a 4-rank quarter-over-quarter rise implies a gradual upward trajectory that will require outpacing faster-moving leaders to convert recent lift into durable top-30 placement.
Notable Products
Blueberry Sugar (3.5g) leads May 2026 with a 102.8% month-over-month surge to rank 1, while Deep Space #6 (3.5g) posts a -61.2% drop at rank 5, indicating a sharp reallocation of demand within the lineup. Neon Flamingo (3.5g) climbs 64.9% to rank 3 as Super Boof (3.5g) falls -40.4% to rank 2, and four of the top ten are Flower SKUs, concentrating momentum in core inhalables. The mix shift toward two triple-digit and high-double-digit Flower gains alongside steep declines implies Kings & Queens is consolidating share around fast-rotating varietals while pruning or de-emphasizing slower performers in May 2026.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
